BioCentury
ARTICLE | Clinical News

BioChem regulatory update

May 28, 1996 7:00 AM UTC

BCHXF received notice of allowance for a European patent claiming invention of substituted 1, 3-oxathiolanes with antiviral properties, including 3TC (lamivudine). The U.S., Canada, Switzerland and A...